Xtant Medical Announces Appointment of Interim CEO

Xtant Medical Holdings Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Michael Mainelli to serve as Interim CEO, replacing Carl O’Connell effective Oct. 12.
 
Mainelli joined the Board of Directors in February 2018 and will remain a member of the Board of Directors while serving as Interim CEO. The company intends to commence a process to recruit a permanent chief executive that will include both internal and external candidates.

Mainelli commented, “I am excited to continue working with our board and with our management team in my new role. Xtant has great products, strong business partners, and dedicated, talented employees.  We will be working hard to drive superior execution.”
 
Board Chairman Jeff Peters said “Mike is a proven leader with over 25 years of successful business leadership in the medical technology industry. He has led businesses at both public and private medical technology companies resulting in growth, operational improvement, and enhanced shareholder value. His unique experience in the global orthopaedic and spinal markets will be particularly valuable, and we are pleased to have him in this interim role.”
 
Mainelli succeeds Carl O’Connell, who served as Xtant’s CEO since October 2016. Peters added, “On behalf of the board, I want to thank Carl O’Connell for his dedication and contributions, notably guiding the company through the recent restructuring process. We wish Carl all the best.”  
 
Xtant Medical Holdings Inc. is a global medical technology company focused on the design, development, and commercialization of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. The company is based in Begrade, Mont.